TROG Cancer Research
Members Login   CQMS Login

TROG 12.01 (HPV Oropharynx)

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)


Weekly Cetuximab/RT Vs Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPVOropharynx)

Final Accrual


Trial Status

Closed to accrual, 7 June 2018

Trial chairpersons

Prof Danny Rischin and A/Prof June Corry

Trial contact

Ania Matera
Biostatisitics and Clinical Trials
BaCT Department, Peter MacCallum Cancer Centre
305 Grattan street, Melbourne, Vic, 3000
Phone: +61 3 8559 7526

Further information

TROG trial 12.01 on Australian Cancer Trials website

Trial resources for TROG members

TROG 12.01 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.